APO XR500 (Metformin XR 500 mg)

Pill imprint APO XR500 has been identified as Metformin hydrochloride extended release 500 mg.

Metformin is used in the treatment of polycystic ovary syndrome; diabetes, type 2; insulin resistance syndrome; female infertility and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for APO XR500

Metformin hydrochloride extended release 500 mg APO XR500 Front
Metformin hydrochloride extended release 500 mg APO XR500 Back
Metformin hydrochloride extended release 500 mg APO XR500
Metformin hydrochloride extended release 500 mg APO XR500
Metformin hydrochloride extended release
Imprint:
APO
XR500
Strength:
500 mg
Color:
White
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Non-sulfonylureas
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-0260
Inactive Ingredients:
silicon dioxide
hypromelloses
magnesium stearate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00904-5794 Major Pharmaceuticals
67544-1081 Prepak Systems Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)